Exciting news! Biocytogen is heading to Fenway for the ARE and BVS Sustainability Expo on April 10, 2025. Hosted at 201 Brookline Ave, this event brings together life sciences leaders committed to environmentally responsible practices. We’ll showcase how our humanized animal models and gene editing platforms support a more sustainable approach to drug discovery. Join us for an afternoon of networking and green innovation!
What is the ARE and BVS Sustainability Expo?
The ARE and BVS Sustainability Expo is part of a multi-site Earth Day Road Show hosted by Alexandria Real Estate and BVS. This initiative brings together the biotech community to spotlight sustainable innovations, promote environmentally responsible practices, and create valuable networking opportunities across leading life science campuses in Massachusetts.
Event Overview
Date: April 10, 2025 | Time: 11:00 AM – 1:30 PM
Venue: Lobby, 201 Brookline Ave, Fenway, MA
Event Schedule
For more event information, please refer to BVS.
About BIOCYTOGEN
Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).
We look forward to seeing you in Fenway!
